Citi raised the firm’s price target on Universal Health Services to $165 from $150 and keeps a Buy rating on the shares. The company reported solid Q1 upside, underscored by strong Behavioral topline trend and margin expansion as Acute, while improving, somewhat lagged turnaround expectations, the analyst tells investors in a research note.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on UHS:
- Universal Health price target raised to $163 from $153 at Credit Suisse
- UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES 2023 FIRST QUARTER FINANCIAL RESULTS
- Universal Health reports Q1 adjusted EPS $2.34, consensus $2.19
- Universal Health upgraded to Equal Weight from Underweight at Barclays
- HCA Healthcare price target raised to $323 from $294 at BofA